Search clinical trials for: Apabetalone

Total 8 results

Laval University
Canadian Institutes of Health Research (CIHR); Resverlogix Corp

Not yet recruiting

Apabetalone for Pulmonary Arterial Hypertension (APPROACH-2)

Pulmonary Arterial Hypertension

Canada
Resverlogix Corp

Completed

Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease (ASSERT)

Coronary Artery Disease | Atherosclerosis

United States
Steeve Provencher
Resverlogix Corp

Completed

Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study (APPRoAcH-p)

Pulmonary Arterial Hypertension

Canada
Resverlogix Corp

Terminated

An Open-Label Study of Apabetalone in Covid Infection

COVID-19 Infection

Canada
Resverlogix Corp

Withdrawn

Safety and Effect of Oral RVX000222 in Subjects With Fabry Disease

Fabry Disease

Canada
Resverlogix Corp

Not yet recruiting

A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis

Kidney Failure, Chronic
Resverlogix Corp

Completed

Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol

Cardiovascular Disease | Atherosclerosis | Dyslipidemia | Acute Coronary Syndrome

United States
Resverlogix Corp
PPD; ICON plc; Medidata Solutions

Completed

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD (BETonMACE)

Coronary Artery Disease | Diabetes Mellitus, Type 2

Netherlands, Taiwan, Argentina, Israel, Poland, Russian Federation, Australia, Belgium, Serbia, Bulgaria, Hungary, Slovakia, Mexico, Croatia, Germany

Search clinical trials for: Apabetalone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations